Literature DB >> 11526205

Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors.

Q R Lu1, J K Park, E Noll, J A Chan, J Alberta, D Yuk, M G Alzamora, D N Louis, C D Stiles, D H Rowitch, P M Black.   

Abstract

The most common primary tumors of the human brain are thought to be of glial cell origin. However, glial cell neoplasms cannot be fully classified by cellular morphology or with conventional markers for astrocytes, oligodendrocytes, or their progenitors. Recent insights into central nervous system tumorigenesis suggest that novel molecular markers might be found among factors that have roles in glial development. Oligodendrocyte lineage genes (Olig1/2) encode basic helix-loop-helix transcription factors. In the rodent central nervous system, they are expressed exclusively in oligodendrocytes and oligodendrocyte progenitors, and Olig1 can promote formation of an chondroitin sulfate proteoglycon-positive glial progenitor. Here we show that human OLIG genes are expressed strongly in oligodendroglioma, contrasting absent or low expression in astrocytoma. Our data provide evidence that neoplastic cells of oligodendroglioma resemble oligodendrocytes or their progenitor cells and may derive from cells of this lineage. They further suggest the diagnostic potential of OLIG markers to augment identification of oligodendroglial tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11526205      PMCID: PMC58563          DOI: 10.1073/pnas.181340798

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

Review 1.  Brain tumors.

Authors:  L M DeAngelis
Journal:  N Engl J Med       Date:  2001-01-11       Impact factor: 91.245

2.  The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene.

Authors:  J Wang; S N Jani-Sait; E A Escalon; A J Carroll; P J de Jong; I R Kirsch; P D Aplan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

3.  Dynamic expression of basic helix-loop-helix Olig family members: implication of Olig2 in neuron and oligodendrocyte differentiation and identification of a new member, Olig3.

Authors:  H Takebayashi; S Yoshida; M Sugimori; H Kosako; R Kominami; M Nakafuku; Y Nabeshima
Journal:  Mech Dev       Date:  2000-12       Impact factor: 1.882

4.  Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss.

Authors:  Y Ino; M C Zlatescu; H Sasaki; D R Macdonald; A O Stemmer-Rachamimov; S Jhung; D A Ramsay; A von Deimling; D N Louis; J G Cairncross
Journal:  J Neurosurg       Date:  2000-06       Impact factor: 5.115

Review 5.  Oligodendroglioma: an appraisal of recent data pertaining to diagnosis and treatment.

Authors:  D Fortin; G J Cairncross; R R Hammond
Journal:  Neurosurgery       Date:  1999-12       Impact factor: 4.654

6.  A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium.

Authors:  M C Raff; R H Miller; M Noble
Journal:  Nature       Date:  1983 Jun 2-8       Impact factor: 49.962

7.  Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors.

Authors:  Q Zhou; S Wang; D J Anderson
Journal:  Neuron       Date:  2000-02       Impact factor: 17.173

8.  Astrocytes give rise to oligodendrogliomas and astrocytomas after gene transfer of polyoma virus middle T antigen in vivo.

Authors:  E C Holland; Y Li; J Celestino; C Dai; L Schaefer; R A Sawaya; G N Fuller
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

9.  Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma.

Authors:  H Hahn; L Wojnowski; K Specht; R Kappler; J Calzada-Wack; D Potter; A Zimmer; U Müller; E Samson; L Quintanilla-Martinez; A Zimmer
Journal:  J Biol Chem       Date:  2000-09-15       Impact factor: 5.157

10.  Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors.

Authors:  Y Shoshan; A Nishiyama; A Chang; S Mörk; G H Barnett; J K Cowell; B D Trapp; S M Staugaitis
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

View more
  51 in total

1.  Post-translational Modifications of OLIG2 Regulate Glioma Invasion through the TGF-β Pathway.

Authors:  Shiv K Singh; Roberto Fiorelli; Robert Kupp; Sindhu Rajan; Emily Szeto; Costanza Lo Cascio; Cecile L Maire; Yu Sun; John A Alberta; Jennifer M Eschbacher; Keith L Ligon; Michael E Berens; Nader Sanai; Shwetal Mehta
Journal:  Cell Rep       Date:  2016-07-07       Impact factor: 9.423

2.  Oligodendroglial-specific transcriptional factor SOX10 is ubiquitously expressed in human gliomas.

Authors:  Sergei I Bannykh; C Claus Stolt; Jung Kim; Arie Perry; Michael Wegner
Journal:  J Neurooncol       Date:  2006-01       Impact factor: 4.130

Review 3.  Cell of origin for malignant gliomas and its implication in therapeutic development.

Authors:  Hui Zong; Luis F Parada; Suzanne J Baker
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-01-29       Impact factor: 10.005

Review 4.  Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2.

Authors:  Dimphna H Meijer; Michael F Kane; Shwetal Mehta; Hongye Liu; Emily Harrington; Christopher M Taylor; Charles D Stiles; David H Rowitch
Journal:  Nat Rev Neurosci       Date:  2012-12       Impact factor: 34.870

Review 5.  Developmental origins and oncogenic pathways in malignant brain tumors.

Authors:  Q Richard Lu; Lily Qian; Xianyao Zhou
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2019-04-03       Impact factor: 5.814

Review 6.  Harnessing OLIG2 function in tumorigenicity and plasticity to target malignant gliomas.

Authors:  Jennifer Kosty; Fanghui Lu; Robert Kupp; Shwetal Mehta; Q Richard Lu
Journal:  Cell Cycle       Date:  2017-08-14       Impact factor: 4.534

7.  OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1.

Authors:  Ying-Wei Lin; Ramona Deveney; Mary Barbara; Norman N Iscove; Stephen D Nimer; Christopher Slape; Peter D Aplan
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

Review 8.  Pathology and molecular genetics of oligodendroglial tumors.

Authors:  Christian Hartmann; Wolf Mueller; Andreas von Deimling
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

9.  Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas.

Authors:  Hideaki Yokoo; Sumihito Nobusawa; Hirohide Takebayashi; Kazuhiro Ikenaka; Koji Isoda; Makoto Kamiya; Atsushi Sasaki; Junko Hirato; Yoichi Nakazato
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 10.  Human embryonic stem cell differentiation toward regional specific neural precursors.

Authors:  Slaven Erceg; Mohammad Ronaghi; Miodrag Stojković
Journal:  Stem Cells       Date:  2009-01       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.